22 min listen
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
ratings:
Length:
97 minutes
Released:
Apr 26, 2024
Format:
Podcast episode
Description
Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://www.researchtopractice.com/PNHThinkTank2024).
CME information and select publications here (https://www.researchtopractice.com/PNHThinkTank2024).
Released:
Apr 26, 2024
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love